santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Phosphodiesterase Inhibitors

  • 1,3-Dipropylxanthine
    A caffeine analog and phosphodiesterase inhibitor that has some selectivity for A2 adenosine receptors. UV lmax = 273 nm, log e=3.98.
    Katalog #CAS NummerSummenformelMenge
    sc-21351331542-62-8C11H16N4O250 mg
  • 4-{[3',4'-(Methylenedioxy)benzyl]amino}-6-methoxyquinazoline
    This substance has been demonstrated to be a specific and potent inhibitor of cGMP-specific phosphodiesterase. It is not shown to have an effect on other PDE isozymes.
    Katalog #CAS NummerSummenformelMenge
    sc-352371150450-42-3C17H15N3O31 mg
  • 7-(β-Hydroxyethyl)-theophylline
    Weak phosphodiesterase inhibitor resembling theophylline in its pharmacological profile. Used as an intermediate in the preparation of 7-substituted xanthines.
    Katalog #CAS NummerSummenformelMenge
    sc-202836519-37-9C9H12N4O35 g
  • 8-Methoxymethyl-IBMX
    Shown to inhibit Cam-PDE which results in an increase in cGMP but not cAMP levels in rabbit aortic slices. Also reported to potentially cause vasodilation and relieve pulmonary artery pressure in rabbits.
    Katalog #CAS NummerSummenformelMenge
    sc-20119278033-08-6C12H18N4O310 mg/50 mg
  • Amrinone
    This compound is a selective cAMP phosphodiesterase (PDE-3) inhibitor with positive inotropic and vasodilatory activity. It is also cardiotonic.
    Katalog #CAS NummerSummenformelMenge
    sc-20728860719-84-8C10H9N3O1 g
  • Anagrelide hydrochloride
    Potent type III phosphodiesterase (PDE3) inhibitor (IC50 = 36 nM). Produces potent thrombocytopenic effects via inhibition of megakaryocyte maturation and inhibits platelet aggregation .
    Katalog #CAS NummerSummenformelMenge
    sc-20351358579-51-4C10H7Cl2N3O.HCl10 mg/50 mg
  • BRL-50481
    The first selective PDE7 inhibitor (Ki=180 nM).
    Katalog #CAS NummerSummenformelMenge
    sc-201178433695-36-4C9H12N2O4S10 mg/50 mg
  • Caffeine
    CNS stimulant. Blocks adenosine A1 and A2A receptors. cAMP phosphodiesterase inhibitor. Interferes with the uptake and storage of Ca2+ by the sarcoplasmic reticulum in skeletal muscle.
    Katalog #CAS NummerSummenformelMenge
    sc-20251458-08-2C8H10N4O25 g
  • CDP 840 hydrochloride
    Katalog #CAS NummerSummenformelMenge
    sc-362723162542-90-7C25H27NO2.HCl10 mg/50 mg
  • Chlorpromazine, Hydrochloride
    Calmodulin-dependent stimulation of cyclic nucleotide phosphodiesterase inhibitor. A peripheral vasodilator. Inhibitor of lysosomal sphingomyelinase and of TNF-α production.
    Katalog #CAS NummerSummenformelMenge
    sc-20253769-09-0C17H19ClN2S•HCl500 mg
  • Cilostamide (OPC 3689)
    A specific phosphodiesterase 3 (PDE3) inhibitor. The compound has been shown to block DNA binding of p-Stat3, increase cAMP levels, and block the effects of insulin and IGF-1 on meiosis
    Katalog #CAS NummerSummenformelMenge
    sc-20118068550-75-4C20H26N2O35 mg/25 mg
  • Cilostazol
    Contains vasodilator, antimitogenic, andtithrombotic, and cardiotonic properties. Also been observed to inhibit mitogenesis, migration of vascular smooth muscle cells, and platelet aggregation.
    Katalog #CAS NummerSummenformelMenge
    sc-20118273963-72-1C20H27N5O210 mg/50 mg
  • CP 80633
    Selective inhibitor of phosphodiesterase type 4 which does not display significant isozyme selectivity of PDE4. Inhibits hydrolysis of cAMP in isolated monocytes, eosinophils, human peripheral blood and T cells. Exhibits anti-inflammatory and bronchodilatory activity in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-205276135637-46-6C18H24N2O310 mg/50 mg
  • Denbufylline
    Selective xanthine derivative that inhibits PDE IV. Has bronchodilatory properties. Exhibits negative inotropic effects by acting on verapamil-sensitive sites of Ca2+ channels in guinea pig ventricle papillary muscle independently of its PDE inhibitory activity.
    Katalog #CAS NummerSummenformelMenge
    sc-20391557076-71-8C16H24N4O35 mg
  • Dipyridamole
    A phosphodiester, cGMP, and non-specific nucleoside transport inhibitor with antioxidant properties.
    Katalog #CAS NummerSummenformelMenge
    sc-20071758-32-2C24H40N8O41 g/5 g
  • EHNA
    An inhibitor of adenosine deaminase (ADA) and a selective inhibitor of cyclic nucleotide phosphodiesterase- 2 (PDE2).
    Katalog #CAS NummerSummenformelMenge
    sc-20118451350-19-7C14H23N5O•HCl10 mg/50 mg
  • Etazolate Hydrochloride
    Selective inhibitor of cAMP-specific phosphodiesterase (PDE IV, IC50=2 µM).
    Katalog #CAS NummerSummenformelMenge
    sc-20118651022-77-6C14H19N5O2 ·HCl5 mg/25 mg
  • Gisadenafil besylate
    Katalog #CAS NummerSummenformelMenge
    sc-361185334827-98-4C23H33N7O5S.C6H6O3S10 mg/50 mg
  • IBMX
    A nonspecific inhibitor of cyclic nucleotide phosphodiesterases. Raises intracellular cyclic AMP levels.
    Katalog #CAS NummerSummenformelMenge
    sc-20118828822-58-4C10H14N4O2200 mg/1 g
  • Ibudilast
    Katalog #CAS NummerSummenformelMenge
    sc-20308050847-11-5C14H18N2O10 mg
  • ICI 63197
    Potent phosphodiesterase (PDE) 4 inhibitor (IC50 = 35 nM for inhibition of [3H]-rolipram binding to rat brain). Antidepressant following systemic administration in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-20360027277-00-5C9H13N5O10 mg/50 mg
  • Mesopram
    Orally active phosphodiesterase (PDE) 4 inhibitor. Inhibits Th1 cell proliferation and decreases production of IFN-γ, TNF-α, IL-10 and iNOS in vitro. Triggers ovulation and exhibits efficacy against experimental autoimmune encephalomyelitis and murine colitis in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-204077189940-24-7C14H19NO410 mg/50 mg
  • Milrinone
    A PDE3 inhibitor that exhibits vasodilator and positive inotropic effects. Can be inhibited by carbachol (sc-202092).
    Katalog #CAS NummerSummenformelMenge
    sc-20119378415-72-2C12H9N3O10 mg/50 mg
  • MY-5445
    An inhibitor of platelet aggregation via an increase in cyclic GMP. Shown to affect cyclic GMP phosphodiesterase and cause relaxation of rat aorta.
    Katalog #CAS NummerSummenformelMenge
    sc-20119578351-75-4C20H14ClN310 mg
  • Obscurolide A1
    Weak phosphodiesterase inhibitor.
    Katalog #CAS NummerSummenformelMenge
    sc-203167144397-99-9C15H17NO51 mg/5 mg
  • Pentoxifylline
    Non-selective phosphodiesterase inhibitor. Inhibits endotoxin-induced synthesis of TNF-α.
    Katalog #CAS NummerSummenformelMenge
    sc-2031846493-05-6C13H18N4O31 g
  • Phosphodiesterase 4 Inhibitor
    Pyrazole compound with a high-affinity active site binding inhibitor of phosphodiesterases IVB and IVD (IC50 = 33 nM and 21 nM). More potent than Rolipram (IC50 = 570 nM and 1.1 µM for PDEIVB and PDEIVD), respectively and greater selectivity over PDEIB, PDEIIA, PDEIIIB, PDEVA, PDEVIIB, PDEVIIIA, PDEIXA and PDEXIA (IC50 > 30 µM) and minimally inhibit PDEXA with an IC50 of 6.9 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-204190346440-86-6C14H15N3O410 mg/50 mg
  • Phosphodiesterase V Inhibitor II
    A cell-permeable tetrahydro-β-carboline-hydantoin compound. Acts as a potent and highly selective phosphodiesterase V inhibitor.
    Katalog #CAS NummerSummenformelMenge
    sc-222167n.n.C24H25N3O35 mg
  • Quazinone (Ro 13-6438)
    Selective inhibitor of cGMP-inhibited phosphodiesterase (PDE III, IC50=0.6 µM).
    Katalog #CAS NummerSummenformelMenge
    sc-20119670018-51-8C11H10ClN3O10 mg/50 mg
  • R-(-)-Rolipram
    Shown to specifically inhibit PDE IV and affect cellular functions. Also reported to demonstrate anti-inflammatory characteristics via reduction of antigen-induced prostaglandin D2 release.
    Katalog #CAS NummerSummenformelMenge
    sc-20119985416-75-7C16H21NO35 mg
  • Ro 20-1724
    A selective inhibitor of cGMP-insensitive PDE4 (type IV phosphodiesterase, PDE IV) found in immune cells which increase endothelial cAMP levels and stabilize the endothelial barrier.
    Katalog #CAS NummerSummenformelMenge
    sc-20070929925-17-5C15H22N2O3100 mg/1 g
  • Rolipram
    Selective inhibitor of cAMP-specific phosphodiesterase (PDE4); promotes apoptosis in HL60 cells through a cAMP-independent mechanism.
    Katalog #CAS NummerSummenformelMenge
    sc-356361413-54-5C16H21NO35 mg/50 mg
  • RS 25344 hydrochloride
    A potent and selective phosphodiesterase (PDE) 4 inhibitor (IC50 values are 0.28, > 100, 160 and 330 nM at PDE4, PDE1, PDE2 and PDE3 respectively). Has been shown to inhibit eosinophil chemotaxis and increase progressive motility of spermatozoa in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-296280152814-89-6C19H13N5O4•HCl•xH2O10 mg/50 mg
  • S-(+)-Rolipram
    An inhibitor of cyclic AMP-specific phosphodiesterase. Ten times less potent than the (R)-(-)-Rolipram isomer. Presents neuroprotection against excitotoxic insult.
    Katalog #CAS NummerSummenformelMenge
    sc-20120085416-73-5C16H21NO35 mg
  • Siguazodan
    PDE III inhibitor, inotropic, vasodilator and antiplatelet agent with sustained activity. Synergizes with PDE IV inhibitors (Roliprams) in blocking antigen-induced bronchospasm in the guinea pig.
    Katalog #CAS NummerSummenformelMenge
    sc-201201115344-47-3C14H16N6O5 mg/25 mg
  • Theobromine
    Weak phosphodiesterase inhibitor and adenosine receptor blocker. Diuretic and smooth-muscle relaxant.
    Katalog #CAS NummerSummenformelMenge
    sc-20329683-67-0C7H8N4O25 g/25 g
  • Theophylline
    Cyclic phosphodiesterase inhibitor. Weakly inhibits alkaline phosphodiesterases and 5’-nucleotidase. Muscle relaxant, cardiac stimulant and diuretic. Used for the treatment of asthma.
    Katalog #CAS NummerSummenformelMenge
    sc-20283558-55-9C7H8N4O25 g/25 g
  • Trequinsin hydrochloride
    Ultrapotent, highly selective inhibitor of cGMP-inhibited phosphodiesterase (PDE lll) in vitro. Potentiates adenosine-stimulated cAMP accumulation.
    Katalog #CAS NummerSummenformelMenge
    sc-35871378416-81-6C24H27N3O3 ·HCl10 mg
  • Vinpocetine
    Selective inhibitor of Ca2+/CaM-PDE with potential neuroprotective and vasodialative properties.
    Katalog #CAS NummerSummenformelMenge
    sc-20120442971-09-5C22H26N2O220 mg/100 mg
  • YM 976
    Orally active inhibits PDE4 (IC50 = 2.2 nM). Low emetogenic activity, suggested to be due to poor brain penetration.
    Katalog #CAS NummerSummenformelMenge
    sc-204411191219-80-4C17H16ClN3O10 mg/50 mg
  • Zaprinast (M&B 22948)
    Katalog #CAS NummerSummenformelMenge
    sc-20120637762-06-4C13H13N5O220 mg/100 mg